中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 11
Nov.  2023
Turn off MathJax
Article Contents

Hepatitis E: From behind the scenes to the front stage

DOI: 10.3969/j.issn.1001-5256.2023.11.001
More Information
  • Corresponding author: CAO Hongcui, hccao@zju.edu.cn(ORCID: 0000-0002-6604-6867)
  • Received Date: 2023-09-18
  • Accepted Date: 2023-10-19
  • Published Date: 2023-11-28
  • Hepatitis E is a type of viral hepatitis caused by hepatitis E virus (HEV) infection. There are four main genotypes of HEV, namely genotypes 1‍ — ‍4. Compared with hepatitis B and hepatitis C, previous research on hepatitis E has made slow progress; however, in recent years, hepatitis E has gradually attracted more attention in China, achieving the transition from behind the scenes to the front stage. First, China has a large population base, a large number of people infected with hepatitis E, and a heavy disease burden, and thus it is necessary to attach great importance to the prevention, diagnosis, and treatment of hepatitis E. Second, the World Health Organization (WHO) has put forward the ambitious goal of eliminating viral hepatitis by 2030, and China has made remarkable achievements in the prevention and treatment of hepatitis B and hepatitis C. At present, the incidence and mortality rates of hepatitis E in China have exceeded those of hepatitis A, and the prevention and treatment of hepatitis E in China is of great significance to actively respond to the call of the WHO. Finally, Chinese researchers in the field of hepatitis E have formed Chinese Consortium for the Study of Hepatitis E, formulated related expert consensus, and established international cooperation platforms, which further promotes the research on hepatitis E in China.

     

  • loading
  • [1]
    EMERSON SU, PURCELL RH. Hepatitis E virus[J]. Rev Med Virol, 2003, 13( 3): 145- 154. DOI: 10.1002/rmv.384.
    [2]
    KAMAR N, DALTON HR, ABRAVANEL F, et al. Hepatitis E virus infection[J]. Clin Microbiol Rev, 2014, 27( 1): 116- 138. DOI: 10.1128/CMR.00057-13.
    [3]
    KAMAR N, BENDALL R, LEGRAND-ABRAVANEL F, et al. Hepatitis E[J]. Lancet, 2012, 379( 9835): 2477- 2488. DOI: 10.1016/S0140-6736(11)61849-7.
    [4]
    LI PF, LIU JY, LI Y, et al. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis[J]. Liver Int, 2020, 40( 7): 1516- 1528. DOI: 10.1111/liv.14468.
    [5]
    World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis[R]. Geneva: World Health Organization, 2016.
    [6]
    National Health Commission Center for Disease Control and Prevention. Action plan to eliminate the public health hazard of hepatitis C( 2021-2030)[EB/OL]. National Health Commission, 2021. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml

    国家卫生健康委员会疾病预防控制局. 消除丙型肝炎公共卫生危害行动工作方案( 2021- 2030 年)[EB/OL]. 国家卫健委, 2021. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml
    [7]
    National Health Commission Center for Disease Control and Prevention. Overview of the national notifiable infectious disease epidemic in 2021[J]. Chin J Viral Dis, 2022, 12( 3): 236.

    国家卫生健康委员会疾病预防控制局. 2021年全国法定传染病疫情概况[J]. 中国病毒病杂志, 2022, 12( 3): 236.
    [8]
    PAN QA, WEDEMEYER H. Global hepatitis E platform[Z]. 2022.
    [9]
    WU J, WANG Y. Introducing a Chinese consortium of hepatitis E[Z]. Global Hepatitis E Platform, 2022.
    [10]
    Chinese Consortium for the Study of Hepatitis E(CCSHE), Chinese Physician Association for Infectious Disease, National Clinical Research Center for Infectious Diseases. Expert consensus on the process of in-hospital screening and management of viral hepatitis E in China(2023)[J]. J Clin Hepatol, 2023, 39( 4): 785- 794. DOI: 10.3969/j.issn.1001-5256.2023.04.008.

    中国戊型肝炎研究协助组(CCSHE), 中国医师协会感染科医师分会, 国家感染性疾病临床医学研究中心. 中国戊型病毒性肝炎院内筛查管理流程专家共识(2023年版)[J]. 临床肝胆病杂志, 2023, 39( 4): 785- 794. DOI: 10.3969/j.issn.1001-5256.2023.04.008.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (317) PDF downloads(145) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return